Hemoglobinopathies Treatment Market Share

Market Share of Hemoglobinopathies Treatment Industry

Global hemoglobinopathies treatment market is moderately fragmented and competitive. Market players are focusing on new product launches, product innovations and geographical expansion. For instance, in May 2017, Sangamo Therapeutics and Pfizer announced a collaboration for the haemophilia A gene therapy. The key market players operating in the market include Sanofi S.A., Global Blood Therapeutics, Inc., bluebird bio, Inc. EMI Holding, Inc. and Celgene Corporation among others.

Hemoglobinopathies Treatment Market Leaders

1. Sanofi S.A.

2. Global Blood Therapeutics, Inc.

3. bluebird bio, Inc.

4. EMI Holding, Inc.

5. Celgene Corporation

*Disclaimer: Major Players sorted in no particular order